Evolution of breast cancer screening in the medicare population: Clinical and economic implications

Journal of the National Cancer Institute

Volumn 106, Issue 8, 2014, Pages

  Killelea, Brigid K ^a,b   Long, Jessica B ^a,b   Chagpar, Anees B ^a,b   Ma, Xiaomei ^a,b   Wang, Rong ^a,b   Ross, Joseph S ^a,b,c   Gross, Cary P ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER SCREENING; COHORT ANALYSIS; COMPUTER ASSISTED RADIOGRAPHY; DIGITAL MAMMOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; VERY ELDERLY;

EID: 84930730781     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju159     Document Type: Article

References (53)

1. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394-1404.
2. Carkaci S, Santiago L, Adrada BE, et al. Screening for breast cancer with sonography. Semin Roentgenol. 2011;46(4):285-291.
3. Cole E, Pisano ED, Brown M, et al. Diagnostic accuracy of Fischer Senoscan Digital Mammography versus screen-film mammography in a diagnostic mammography population. Acad Radiol. 2004;11(8):879-886.
4. Lewin JM, D'Orsi CJ, Hendrick RE, et al. Clinical comparison of fullfield digital mammography and screen-film mammography for detection of breast cancer. Am J Roentgenol. 2002;179(3):671-677.
5. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783.
6. Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program - the Oslo II Study. Radiology. 2004;232(1):197-204.
7. Skaane P, Young K, Skjennald A. Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading - Oslo I study. Radiology. 2003;229(3):877-884.
8. Birdwell RL, Ikeda DM, O'Shaughnessy KF, et al. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. Radiology. 2001;219(1):192-202.
9. Brem RF, Baum J, Lechner M, et al. Improvement in sensitivity of screening mammography with computer-aided detection: a multiinstitutional trial. Am J Roentgenol. 2003;181(3):687-693.
10. Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology. 2001;220(3):781-786.
11. Skaane P, Hofvind S, Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in populationbased screening program: follow-up and final results of Oslo II Study. Radiology. 2007;244(3):708-717.
12. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151-2163.
13. Corsetti V, Houssami N, Ferrari A, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539-544.
14. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221(3):641-649
15. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23(33):8469-8476.
16. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103(9):1898-1905.
17. Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer. 2007;43(13):1905-1917.
18. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-26, W-236.
19. Fenton JJ, Green P, Baldwin LM. Internal validation of procedure codes on Medicare claims for digital mammograms and computer-aided detection. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2186-2189.
20. Tohno E, Ueno E, Watanabe H. Ultrasound screening of breast cancer. Breast Cancer. 2009;16(1):18-22.
21. Burkhardt JH, Sunshine JH. Core-needle and surgical breast biopsy: comparison of three methods of assessing cost. Radiology. 1999;212(1):181-188.
22. Chubak J, Boudreau DM, Fishman PA, et al. Cost of breast-related care in the year following false positive screening mammograms. Medical Care. 2010;48(9):815-820.
23. Warren JL, Brown ML, Fay MP, et al. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol. 2002;20(1):307-316.
24. Yabroff KR, Lamont EB, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630-641.
25. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am. 2010;48(5):879-891.
26. Lindfors KK, Rosenquist CJ. The cost-effectiveness of mammographic screening strategies. JAMA. 1995;274(11):881-884.
27. Stout NK, Rosenberg MA, Trentham-Dietz A, et al. Retrospective costeffectiveness analysis of screening mammography. J Natl Cancer Inst. 2006;98(11):774-782.
28. National Cancer Institute. SEER-Medicare Linked Databases. http:// healthservices.cancer.gov/seermedicare/. Accessed October 12, 2012
29. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258-1267.
30. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care. 2005;43(11):1130-1139.
31. Smith-Bindman R, Quale C, Chu PW, et al. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care. 2006;44(5):463-470.
32. Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(8 Suppl):IV-104-17.
33. Riley GF, Potosky AL, Lubitz JD, et al. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care. 1995;33(8):828-841.
34. Office of Information Services. Table 6 Number of Medicare Enrollees, by Demographic Characteristics, Type of Coverage, Type of Entitlement, Type of Payment, Buy-in Status, and Residence: July 1, 2001. Bethesda, MD: Centers for Medicare and Medicaid Services; 2003.
35. Office of Information Services. Table 6A. Number of Medicare Enrollees, by Demographic Characteristics, Type of Coverage, Type of Entitlement,Type of Payment, Buy-in Status, and Residence: July 1, 2002. Bethesda, MD: Centers for Medicare and Medicaid Services; 2004.
36. Office of Information Services. Medicare Enrollment Table 2.2: Total, Fee-for-Service and Managed Care Enrollees, by Demographic Characteristics as of July 1, 2007. Bethesda, MD: Centers for Medicare and Medicaid Services; 2008.
37. Office of Information Services. Table 2.2. Medicare Enrollment: Hospital Insurance and/or Supplementary Medical Insurance Programs for Total, Fee-for-Service and Managed Care Enrollees, by Demographic Characteristics as of July 1, 2008. Bethesda, MD: Centers for Medicare and Medicaid Services; 2009.
38. Gross CP, Long JB, Ross JS, et al. The cost of breast cancer screening in the Medicare population. JAMA Intern Med. 2013;173(3):220-226
39. Braithwaite D, Zhu W, Hubbard RA, et al. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013;105(5):334-341.
40. van Schoor G, Otten JD, den Heeten GJ, et al. Breast cancer among women over 75 years: an important public health problem? Eur J Public Health. 2012;22(3):422-424.
41. Walter LC, Lindquist K, Covinsky KE. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Intern Med. 2004;140(9):681-688.
42. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737.
43. Rao VM, Levin DC, Parker L, et al. Recent trends in mammography utilization in the Medicare population: is there a cause for concern? J Am Coll Radiol. 2008;5(5):652-656.
44. Pisano ED, Hendrick RE, Yaffe MJ, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST1. Radiology. 2008;246(2):376-383.
45. Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center 1. Radiology. 2001;220(3):781-786.
46. Skaane P, Kshirsagar A, Stapleton S, et al. Effect of computer-aided detection on independent double reading of paired screen-film and full-field digital screening mammograms. Am J Roentgenol. 2007;188(2):377-384.
47. Fenton JJ, Taplin SH, Carney PA, et al. Influence of computer-aided detection on performance of screening mammography. New Engl J Med. 2007;356(14):1399-1409.
48. Fenton JJ, Xing G, Elmore JG, et al. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med. 2013;158(8):580-587.
49. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA. 2003;289(24):3243-3253.
50. Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol. 2012;120(3):595-603.
51. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011;117(10):2209-2218.
52. Katz SJ, Morrow M. The challenge of individualizing treatments for patients with breast cancer. JAMA. 2012;307(13):1379-1380.
53. Tosteson AN, Stout NK, Fryback DG, et al. Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med. 2008;148(1):1-10.